😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

Galapagos NV (GLPG)

TradeGate
Currency in EUR
Disclaimer
24.36
+0.12(+0.50%)
Delayed Data
Earnings results expected in 10 days
Fair Value
Day's Range
24.1224.36
52 wk Range
23.0239.91
Bid/Ask
24.30 / 24.34
Prev. Close
24.24
Open
24.12
Day's Range
24.12-24.36
52 wk Range
23.02-39.91
Volume
490
Average Volume (3m)
8,696
1-Year Change
-37.53%
Fair Value
Unlock
Fair Value Upside
Unlock
GLPG Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
36.73
Upside
+50.04%
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Compare GLPG to Peers and Sector

Metrics to compare
GLPG
Peers
Sector
Relationship
P/E Ratio
0.0x−0.9x−0.6x
PEG Ratio
0.00−0.130.00
Price/Book
0.0x1.3x2.6x
Price / LTM Sales
0.0x5.0x3.1x
Upside (Analyst Target)
0.0%1,122.1%57.9%
Fair Value Upside
Unlock23.7%8.4%Unlock

People Also Watch

855.90
ASML
+3.18%
14.16
UMI
+1.14%
17.06
INGA
+1.37%
16.84
ALFEN
-0.38%
16.41
ABNd
+0.95%

Galapagos NV Company Profile

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.